The Cancer Moonshot: A perspective in 4 graphs
Despite assurances, subsidies won’t save many from big health insurance rate increases
Cross-border media comparison: Insurance coverage linked to news coverage of expensive cystic fibrosis drug
Media mystery: Why did journalists ignore an important study on a costly, harmful back pain procedure?
Is more testing really the way to save American healthcare?
With coupon programs, drug industry hides ballooning costs of expensive new medicines
Was Turing Pharmaceuticals’ 5000% price increase a tipping point?
NIH SPRINT study sparks questions about overtreatment of mild hypertension
Dr. Richard Lehman: Why does having abnormal glucose tests cost the USA $245bn?
Bankrupted by cancer: Why “cost” is an important criterion in our review process